Literature DB >> 6349560

Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys.

I S Blakebrough, B M Greenwood, H C Whittle, A K Bradley, H M Gilles.   

Abstract

A combined group A and group C meningococcal polysaccharide vaccine was given to 438 Nigerian schoolboys shortly before an outbreak of group A meningococcal disease occurred in their school. Four months after vaccination the carriage rate of group A meningococci among vaccinated subjects (11%) was no different from that found among the controls (12%), although a good antibody response to both components of the vaccine was observed. One case of group A meningococcal disease was recorded amongst 438 vaccinated subjects while five cases occurred among 874 controls.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6349560     DOI： 10.1080/00034983.1983.11811694

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


  10 in total

Review 1.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 2.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection.

Authors:  A L Davies; D O'Flanagan; R L Salmon; T J Coleman
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

4.  Comparison of different vaccines and induced immune response against Campylobacter jejuni colonization in the infant mouse.

Authors:  A G Abimiku; J M Dolby; S P Borriello
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

5.  Surveillance and control of meningococcal meningitis epidemics in refugee populations.

Authors:  P S Moore; M J Toole; P Nieburg; R J Waldman; C V Broome
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

6.  Carriers of Neisseria meningitidis in household contacts of meningococcal disease cases in Catalonia (Spain).

Authors:  N Cardeñosa; A Domínguez; A Orcau; H Pañella; P Godoy; S Minguell; N Camps; J A Vázquez
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Development and evaluation of an improved mouse model of meningococcal colonization.

Authors:  Kyungcheol Yi; David S Stephens; Igor Stojiljkovic
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

8.  Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.

Authors:  Rolando Pajon; Andrew M Fergus; Oliver Koeberling; Dominique A Caugant; Dan M Granoff
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

9.  Meningococcal conjugate vaccines: optimizing global impact.

Authors:  Andrew Terranella; Amanda Cohn; Thomas Clark
Journal:  Infect Drug Resist       Date:  2011-09-21       Impact factor: 4.003

10.  Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis.

Authors:  L V Cooper; P A Kristiansen; H Christensen; A Karachaliou; C L Trotter
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.